×
Hero Background

Xanthoma Companies

ID: MRFR/Pharma/3432-HCR
110 Pages
Rahul Gotadki
October 2025

Dedicated to addressing xanthoma-related medical challenges, Xanthoma companies engage in research and development to provide effective diagnostics and treatments. These companies aim to enhance the understanding and management of xanthoma conditions for improved patient care.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Xanthoma Market

Xanthoma Market

 


Latest Xanthoma Companies Updates:


A June 2023 study in the Journal of Clinical Lipidology explored the effectiveness of various treatments for xanthomas associated with familial hypercholesterolemia.An August 2023 article in The American Journal of Dermatopathology discussed the diagnostic features of different types of xanthoma.


AstraZeneca and Sanofi have ongoing development programs for cholesterol-lowering medications and treatments for conditions linked to xanthoma. These advancements could indirectly impact future xanthoma management.


List of Xanthoma Key companies in the market:



  • Teva Pharmaceutical Industries

  • AstraZeneca PLC

  • Sanofi

  • Bayer HealthCare Pharmaceuticals LLC

  • Johnson & Johnson

  • Pfizer Inc.

  • GlaxoSmithKline PLC

  • Novo Nordisk

  • Novartis International AG